Autoimmune Epilepsy: Emerging Trends*
Time: 12:00 PM to 1:00 PM
Description
Epilepsy, characterized by recurrent seizures, can have a significant impact on quality of life. While the causes are diverse, recent research has shed light on the intriguing link between autoimmunity and certain types of epilepsy. This workshop aims to investigate the emerging trends in diagnosis and treatment of autoimmune seizures. To understand and manage autoimmune epilepsy effectively, we differentiate between syndromes caused by specific autoantibodies and those mediated by T-cells. We distinguish between acute, symptomatic seizures as a first event and a more chronic tendency towards autoimmune-associated epilepsy. We will delve into the mechanisms by which autoimmunity might trigger seizures, discuss the latest diagnostic tools for identifying these autoimmune epilepsies, and explore promising avenues for treatment strategies. This conference strives to improve diagnosis, treatment options, and ultimately, the lives of individuals living with autoimmune epilepsy.
Objectives
Describe the seizure semiology and EEG patterns suggestive of autoimmune seizures and learn about common immune mediated encephalitides associated with seizures.
Utilize appropriate diagnostic tools to detect autoimmune seizures and treat them appropriately with immunotherapy.
Assess response of therapy and decide escalation if needed.
Speakers
Identification of Autoimmune Epilepsy Syndromes
DescriptionIn this session we will discuss presentation and semiology of autoimmune encephalitis syndromes, clues to diagnosis, treatment and outcome.
SpeakersImmunotherapy in Autoimmune Epilepsy: An Experience from Autoimmune Epilepsy Clinic
DescriptionIn this presentation Dr. Gupta will discuss the immunotherapies in autoimmune epilepsy; both acute and long-term immunotherapies.
SpeakersNavigating the Expanding Spectrum of Neural Specific Antibodies Associated with Autoimmune Encephalitis
DescriptionPopulation-based studies have demonstrated both autoimmune and viral causes have similar prevalence and incident rates. Repertoire of autoimmune biomarkers has considerably increased with discovery of many novel neural antibodies. Early diagnosis and immunomodulatory treatment remain the cornerstone of management, to halt the underlying neuro-inflammatory process and prevent permanent neuronal injury. The availability of serological testing and various imaging modalities has further improved early diagnosis and prompt management of autoimmune encephalitis.
Speakers